about
The Iceberg Nature of Fibromyalgia Burden: The Clinical and Economic AspectsSevere forms of fibromyalgia with acute exacerbation of pain: costs, comorbidities, and length of stay in inpatient care.Virtual reality exposure therapy as treatment for pain catastrophizing in fibromyalgia patients: proof-of-concept study (Study Protocol)Societal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domains.Improving the primary care physicians' decision making for fibromyalgia in clinical practice: development and validation of the Fibromyalgia Detection (FibroDetect®) screening tool.Which aspects of health differ between working and nonworking women with fibromyalgia? A cross-sectional study of work status and health.Duloxetine for the treatment of fibromyalgia.Fibromyalgia with severe forms of progression in a multidisciplinary therapy setting with emphasis on hyperthermia therapy--a prospective controlled study.The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States.Mast Cell Stabilizer (Ketotifen) in Fibromyalgia: Phase 1 Randomized Controlled Clinical Trial.Resistance exercise improves muscle strength, health status and pain intensity in fibromyalgia--a randomized controlled trialPredictors of duloxetine adherence and persistence in patients with fibromyalgia.Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States.Resource utilisation and direct costs in patients with recently diagnosed fibromyalgia who are offered one of three different interventions in a randomised pragmatic trial2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary.Decrease of fear avoidance beliefs following person-centered progressive resistance exercise contributes to reduced pain disability in women with fibromyalgia: secondary exploratory analyses from a randomized controlled trialReal-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia.A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience.Communication preferences in patients with fibromyalgia syndrome: descriptive results and patient characteristics as predictors.Musculoskeletal sensitization and sleep: chronic muscle pain fragments sleep of mice without altering its durationEmerging therapies for fibromyalgia: an update.Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study.A systematic review of risk factors associated with transitioning from regional musculoskeletal pain to chronic widespread pain.Economics of medically unexplained symptoms: a systematic review of the literature.Effects of cardiovascular comorbidities on work participation in rheumatic diseases: a prospective cohort study among working individuals.Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden.Women with fibromyalgia's experience with three motion-controlled video game consoles and indicators of symptom severity and performance of activities of daily living.Fibromyalgia: A Critical and Comprehensive Review.Clinical Characteristics of Fibromyalgia in a Chronic Pain Population.Work ability in fibromyalgia: an update in the 21st century.Factors promoting sustainable work in women with fibromyalgia.The costs associated with sleep symptoms among patients with fibromyalgia.Characteristics of suitable work from the perspective of patients with fibromyalgia.Randomized Controlled Trial of Acupuncture for Women with Fibromyalgia: Group Acupuncture with Traditional Chinese Medicine Diagnosis-Based Point Selection.
P2860
Q26801572-01468179-C535-4623-8178-F7AE725940AFQ33766468-315B1EB3-8B4F-431B-B6E5-B46B01B37A18Q33884944-74CD38E7-2BA1-435E-9832-F0BE21F5A6F3Q34160641-7453CB70-AA17-4CC0-A4CB-25BC1CA0D7F1Q34459894-86C42276-0317-4126-BC85-2475E164523BQ34511430-15EA6AA9-3C14-4043-A5C0-AEFB93E86EE8Q34663934-26347091-907A-49D6-8FAB-720EFA12036CQ34787178-AE16D1F2-9899-4A66-99D6-26EBFF1E55FAQ35231146-EB2D5ED3-A197-4B0A-8463-33822615EDB0Q35563612-63A902DB-B2C4-452F-9B80-497582B21482Q35810439-01435DB9-3AC0-4273-9434-F8643DB31758Q36084689-76602B26-3DF5-4CAE-BB73-260D55FA3D48Q36797580-EA42A215-5ADA-47A1-80DD-A333A5A854D0Q36834489-DC835A63-E32A-4252-A4BD-9ED066A4EA37Q36905958-76CBFC05-6E30-4741-AF7E-26F2790A7F8AQ36923412-07D3B897-16DF-4A44-90D8-6AA5C9360DA1Q37478527-EA787840-D2FF-4963-9D79-D36A11679A02Q37517925-5B6A77A5-2645-493B-B434-7A1F5F421A82Q37568304-C08B335E-773D-4485-A94D-66BA60627798Q37576295-55684CB9-69D7-40DE-B598-4C0EC7903F73Q37756999-E46897E9-E5EF-4512-A513-824B6C70A4BFQ37844532-CD8DBA18-9373-4697-A67B-C7F71D7E5B11Q37987883-B523C6C6-F8B5-4F9C-8B40-492B07152EF3Q38029474-1ECC48C7-A1A5-4E5C-BF5D-E4C84D66036AQ38127400-27885220-F5A1-41BE-8D64-6F7A0A167A16Q38185990-6F16D526-498D-4070-93DD-699C4B65E612Q38548118-C84ECA67-73EF-42DA-A334-3A0B7FD0A4B6Q38601633-4DBBB42D-8AAE-469D-A7F7-92B81E553B90Q38831991-932B668E-041A-4E3B-A638-3EE64EABFC83Q39278819-93EEF4E6-2664-42DC-9172-22BF74F9DA0BQ40086829-EFC48168-C0C9-4DC4-8EF6-9F5EEA637F08Q44173534-6D29C63B-7913-4FED-85F1-3CE38F16F323Q48563396-C6056186-160D-409D-973E-0688534849C5Q49977735-4FAD8172-CE92-4F65-B2F4-8366B844EF75
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Societal and patient burden of fibromyalgia syndrome.
@en
Societal and patient burden of fibromyalgia syndrome.
@nl
type
label
Societal and patient burden of fibromyalgia syndrome.
@en
Societal and patient burden of fibromyalgia syndrome.
@nl
prefLabel
Societal and patient burden of fibromyalgia syndrome.
@en
Societal and patient burden of fibromyalgia syndrome.
@nl
P2093
P1433
P1476
Societal and patient burden of fibromyalgia syndrome.
@en
P2093
Charles Taïeb
Katell Le Lay
Lieven Annemans
P304
P356
10.2165/11313650-000000000-00000
P577
2009-01-01T00:00:00Z
P6179
1019504297